Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000006

Chief Medical Officer sold 621 shares at $50.02 ($31,063)

  • Chief Medical Officer acquired 621 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bowden Christopher · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-11 Exercise or conversion : show line 1 in the form +621 $35.16 $21,834 2,271 D
2020-02-11 Sale : show line 2 in the form −621 $50.02 $31,063 1,650 D
Open-market sales · 621 sh · avg $50.02 · $31,063

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-02-11 Exercise or conversion : show line 3 in the form Stock option (right to buy) −621 26,406 D
Loading xslF345X03/wf-form4_158162886617100.xml…